Management Comment Nabi, President and Chief Executive Officer of Emergent BioSolutions of our biosciences business last August, we have chosen Aptevo Therapeutics Inc.s name, identified its board of directors, and now received a favorable IRSoff. Our next steps include selecting the Aptevo senior management team, filing with and obtaining clearance from the Securities and Exchange Commission”